[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570166":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":45,"responsibleParty":63,"collaborators":25,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":25,"eligibilityCriteria":71,"healthyVolunteers":72,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":25,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":25,"overallStatus":48,"whyStopped":25,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"JW Pharmaceutical","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Test group (JW2286)","EXPERIMENTAL","Ethnicity: Korean or Caucasian",[13],"Drug: JW2286",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo group (Placebo of JW2286)","PLACEBO_COMPARATOR",[18],"Drug: Placebo of JW2286",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","JW2286","a single administration of JW2286 per dose",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo of JW2286","a single administration of Placebo of JW2286 per dose",[15],[31],{"name":32,"affiliation":33,"role":34},"SeungHwan Lee","Seoul National University Hospital","PRINCIPAL_INVESTIGATOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},"Hyeona Kim","CONTACT","+82-840-6791","hyeona.kim@jwhealthcare.com",{"name":42,"role":38,"phone":43,"phoneExt":25,"email":44},"Soojin Park","+82-2-840-6166","park.soojin@jwhealthcare.com",[46],{"facility":47,"status":48,"city":49,"state":25,"zip":25,"country":50,"countryCode":25,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Seoul National University Hospital Clinical Trial Center","RECRUITING","Seoul","South Korea",{"type":52,"coordinates":53},"Point",[54,55],126.9784,37.566,{"lat":55,"lon":54},[58,62],{"name":59,"role":38,"phone":60,"phoneExt":25,"email":61},"Jaegu Kang","+82-2072-1666","rkdworn489@snu.ac.kr",{"name":32,"role":38,"phone":25,"phoneExt":25,"email":25},{"type":64,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100570166","phase-1-to-evaluate-the-safetytolerability-and-pharmacokinetic-characteristics-in-healthy-volunteers-100570166",false,"NCT06703710","To Evaluate the Safety\u002FTolerability and Pharmacokinetic Characteristics in Healthy Volunteers","A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Phase 1 Clinical Trial to Evaluate the Safety\u002FTolerability and PK Characteristics, and to Explore Food Effect and Ethnic Difference of JW2286 in Healthy Volunteers","Inclusion Criteria:\n\n* Healthy Korean or Caucasian volunteers\n\nExclusion Criteria:\n\n* Individuals with a clinically significant disease or history\n* Individuals with a history of a gastrointestinal disorder or surgery\n* In the case of all female individuals with childbearing potential, except for those who are surgically sterile",true,"ALL","19 Years","50 Years",{"count":77,"type":78},72,"ESTIMATED","INTERVENTIONAL",[81],"PHASE1","This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety\u002Ftolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.",[84],"Healthy","2025-01-09",{"date":87,"type":88},"2025-01-13","ACTUAL",{"date":90,"type":88},"2025-01-06",{"date":92,"type":78},"2026-01",{"name":5,"class":6},1]